A brief personal history of cancer immunotherapy at Stanford: if these walls could talk….
This is a journey that began in medical school at Stanford in 1963 and that is still underway, now as faculty member here for the past 40 years. History is by its nature selective, and I chose highlights that reflect on the remarkable progress we have made using the immune system to treat cancer. We will never be satisfied until we eliminate suffering and early mortality from cancer, but the progress is indeed remarkable as are the people who have contributed to it.
Stanford University School of Medicine, Stanford, CA, USA, levy@stanford.edu.
Ron
R
Levy
D000911:Antibodies, Monoclonal / Q000627:therapeutic use; D000970:Antineoplastic Agents / Q000627:therapeutic use; D002140:California; D005178:Faculty; D049673:History, 20th Century; D049674:History, 21st Century; D006801:Humans; D007167:Immunotherapy / Q000266:history / Q000639:trends; D009369:Neoplasms / Q000276:immunology / Q000628:therapy; D012577:Schools, Medical
D000911:Antibodies, Monoclonal; D000970:Antineoplastic Agents